<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Causes of acute toxic-metabolic encephalopathy in children and their clinical features</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Causes of acute toxic-metabolic encephalopathy in children and their clinical features</h1>
<div class="graphic"><div class="figure"><div class="ttl">Causes of acute toxic-metabolic encephalopathy in children and their clinical features</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="15%"></colgroup><colgroup span="3" width="10%"></colgroup><colgroup width="15%"></colgroup><colgroup width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Diagnosis</td> <td class="subtitle1">Mental status changes</td> <td class="subtitle1">Seizures</td> <td class="subtitle1">Focal neurologic signs</td> <td class="subtitle1">Elevated ICP</td> <td class="subtitle1">Characteristic neuroimaging findings</td> <td class="subtitle1">Other features</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Hypoxic-ischemic encephalopathy</td> </tr> <tr> <td class="indent1"> </td> <td>Ranges from lethargy to coma*</td> <td class="centered">++</td> <td class="centered">++</td> <td class="centered">+</td> <td class="centered">Edema, infarction, restricted DWI signal changes</td> <td> <ul> <li>Typically a straightforward diagnosis after an obvious precipitating event, such as drowning, airway obstruction, or cardiopulmonary arrest</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="7">Sepsis</td> </tr> <tr> <td class="indent1"> </td> <td>Ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)</td> <td class="centered">+/–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">T2 FLAIR and restricted DWI signal changes</td> <td> <ul> <li>Signs of systemic infection (eg, fever, elevated WBC)</li> <li>Diagnosis is confirmed with appropriate microbiology studies</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="7">Metabolic disorders</td> </tr> <tr> <td class="indent1">Hypoglycemia</td> <td>Ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">++</td> <td class="centered">+</td> <td class="centered">+/–</td> <td class="centered">–</td> <td> <ul> <li>Signs of increased epinephrine release (eg, tremor, diaphoresis) may be present, but are not universal</li> </ul> </td> </tr> <tr> <td class="indent1">Diabetic ketoacidosis</td> <td>Ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">+/–</td> <td class="centered">–</td> <td class="centered">+</td> <td class="centered">Cerebral edema</td> <td> <ul> <li>Nausea, vomiting, abdominal pain, hyperventilation (Kussmaul breathing)</li> <li>May occur in new-onset DM or as a complication of known DM</li> </ul> </td> </tr> <tr> <td class="indent1">Inborn errors of metabolism</td> <td>Ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td colspan="4">Depends on specific disorder<sup>¶</sup></td> <td> <ul> <li>Patients may have recurrent episodes of encephalopathic changes associated with vomiting and hypotonia that may be associated with an intercurrent illness or prolonged fasting</li> <li>Laboratory abnormalities may include hypoglycemia, hyperammonemia, or lactic acidosis, depending on the type of inborn error of metabolism<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="7">Electrolyte derangements</td> </tr> <tr> <td class="indent1">Hypernatremia</td> <td>Ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">+</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">Pontine or extrapontine myelinolyses</td> <td> <ul> <li>Nonspecific initial manifestations include irritability, restlessness, weakness, vomiting, muscular twitching, fever, and, in infants, high-pitched cry and tachypnea</li> <li>Encephalopathy is not typically seen until serum sodium level exceeds 160 mEq/L</li> <li>Most common cause of hypernatremia in children is excessive fluid losses; patients may have manifestations of hypovolemia, including tachycardia, dry mucous membranes, and poor peripheral perfusion</li> </ul> </td> </tr> <tr> <td class="indent1">Hyponatremia</td> <td>Ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">++</td> <td class="centered">–</td> <td class="centered">+</td> <td class="centered">Edema; pontine or extrapontine myelinolyses</td> <td> <ul> <li>Neurologic symptoms are typically observed with plasma sodium levels &lt;125 mEq/L</li> <li>Severe symptoms (lethargy, obtundation, and seizures) may occur as the level falls below 120 mEq/L</li> </ul> </td> </tr> <tr> <td class="indent1">Hypercalcemia</td> <td>Irritability, behavioral changes; ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">+/–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td> <ul> <li>Anorexia, nausea, vomiting, hypertension, bradycardia, nephrocalcinosis, pruritus, headache, weakness</li> <li>Life-threatening symptoms may occur with serum concentrations &gt;15 mg/dL (3.75 mmol/L)</li> </ul> </td> </tr> <tr> <td class="indent1">Hypocalcemia</td> <td>Ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">++</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td> <ul> <li>Tetany, positive Trousseau and Chvostek signs, laryngospasm</li> </ul> </td> </tr> <tr> <td class="indent1">Hypermagnesemia</td> <td>Ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">–</td> <td class="centered">Fixed dilated pupils</td> <td class="centered">–</td> <td class="centered">–</td> <td> <ul> <li>Weakness, respiratory depression, hypotension, ECG changes</li> </ul> </td> </tr> <tr> <td class="indent1">Hypomagnesemia</td> <td>Delirium, irritability, hallucinations; ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">+</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td> <ul> <li>Tremors, muscle twitching, myoclonic jerks, choreiform movements, and nystagmus; coma and generalized seizures may occur in severe cases</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="7">Endocrine disorders</td> </tr> <tr> <td class="indent1">Hypothyroidism</td> <td>Apathy, slow cognition, psychosis; ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td> <ul> <li>Hyponatremia, hypothermia, bradycardia, central hypoventilation</li> <li>History of fatigue, weight gain, constipation, and cold intolerance</li> <li>A precipitating trigger (eg, infection, burn) may be present</li> </ul> </td> </tr> <tr> <td class="indent1">Hyperthyroidism</td> <td>Agitation, irritability, psychosis, and, rarely, coma</td> <td class="centered">+/–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td> <ul> <li>Tremor, tachycardia, cardiac dysrhythmias, hypertension fever, fatigue, weight loss</li> </ul> </td> </tr> <tr> <td class="indent1">Adrenal crisis</td> <td>Delirium; mood and behavioral changes; cognitive impairments; psychosis; hallucinations; ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td> <ul> <li>Hypotension, nausea and vomiting, abdominal pain, fever, hyponatremia, hyperkalemia</li> <li>Potential triggers include dehydration, trauma, surgery, infection, or other physical stress or stopping glucocorticoid treatment</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="7">Hypertension</td> </tr> <tr> <td class="indent1"> </td> <td>Irritability, anxiety, agitation</td> <td class="centered">PRES: ++<br/> HTE: +</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">Cortical and white matter signal changes in parieto-occipital region T2 and FLAIR</td> <td> <ul> <li>Severe hypertension</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="7">Organ failure</td> </tr> <tr> <td class="indent1">Hepatic failure</td> <td>Delirium, apathy; ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">+</td> <td class="centered">Decerebrate/decorticate posture</td> <td class="centered">+</td> <td class="centered">Edema</td> <td> <ul> <li>Jaundice, ascites, and other clinically evident signs of liver failure are usually present</li> <li>Asterixis, grimacing, jerking movements</li> </ul> </td> </tr> <tr> <td class="indent1">Renal failure/uremia</td> <td>Disorientation, hallucinations, rambling speech; ranges from mild (eg, confusion, disorientation, lethargy) to severe (eg, coma)*</td> <td class="centered">+</td> <td class="centered">–</td> <td class="centered">–</td> <td class="centered">–</td> <td> <ul> <li>Laboratory evidence of severe renal impairment</li> <li>Anorexia, tremor, weakness, peripheral neuropathy, myoclonus, and asterixis ("uremic flap")</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="7">Reye syndrome</td> </tr> <tr> <td class="indent1"> </td> <td>Confusion, rapidly evolves to coma</td> <td class="centered">++</td> <td class="centered">+/–</td> <td class="centered">++</td> <td class="centered">Edema, restricted DWI signal changes</td> <td> <ul> <li>Hepatomegaly, markedly elevated transaminases, hyperammonemia, hypoglycemia, metabolic acidosis</li> <li>Typically begins several days after apparent recovery from a viral illness, especially varicella or influenza A or B</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="7">Drugs and toxins</td> </tr> <tr> <td class="indent1"> </td> <td colspan="6">Depends on specific agent<sup>Δ</sup></td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>ICP: intracranial pressure; DWI: diffusion-weighted imaging; FLAIR: fluid attenuation inversion recovery; WBC: white blood cell; DM: diabetes mellitus; ECG: electrocardiogram; PRES: posterior reversible encephalopathy syndrome; HTE: hypertensive encephalopathy.</p>
<p>* The severity of encephalopathy generally reflects the degree of metabolic derangement or hypoxic insult, with the exception of uremic encephalopathy, in which the severity of encephalopathy does not always correlate with the degree of azotemia.</p>
<p>¶ Refer to separate UpToDate content on inborn errors of metabolism for additional details.</p>
Δ Numerous drugs and toxins can cause encephalopathy in children. Broad categories include sedatives (eg, benzodiazepines, barbiturates, alcohol, opiates), anticholinergic agents (eg, tricyclic antidepressants, antipsychotic medication, antihistamines), antiseizure medications (eg, phenytoin, carbamazepine, valproate), salicylates, immunosuppressive agents, antibiotics, and environmental toxins (eg, lead, organophosphates). Refer to separate UpToDate content on these agents for further details.</div><div id="graphicVersion">Graphic 110254 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
